We completed this study by determining in one low-grade and three high-grade glioma-derived cultures the expression of the neural stem cell markers Prominin/CD133 and SSEA1/CD15 as well as the levels of embryonal/neural stem cells and mesenchymal markers as compared to neural stem cells. The gene discussed is PROM1; the disease is central nervous system cancer.